Lupus (DBCOND0030198)

Identifiers

Synonyms
Discoid lupus erythematosus / Lupus erythematosus / Lupus erythematosus (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Cyclophosphamide
A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06445127
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)No drug interventionsdiagnosticNot Availablerecruiting
NCT05715463
Rheumatology-based Adaptive Intervention for Social Determinants and Health EquityNo drug interventionsotherNot Availableactive_not_recruiting
NCT03402087
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patientstreatment1completed
NCT00339261
Disease Progression and Activity in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT02857452
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) QuestionnaireNo drug interventionsNot AvailableNot Availablecompleted
NCT01164917
Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusNo drug interventionstreatment1terminated
NCT03825224
Evaluation of MyoStrain™ in Clinical PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT05018858
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for LupusNo drug interventionstreatment1recruiting
NCT05922722
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With LupusNo drug interventionsNot AvailableNot Availablerecruiting
NCT00068874
Improving Quality of Life for African American Female Adolescents With LupusNo drug interventionstreatment2completed
NCT04334031
Deployment o the Multidisciplinary Prospective Cohort ImminentNo drug interventionsotherNot Availablerecruiting
NCT03142412
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment OptimizationNo drug interventionsNot AvailableNot Availableunknown_status
NCT06013995
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of LupusNo drug interventionstreatment1recruiting
NCT05321108
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic LupusNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT03953690
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in FranceNo drug interventionsNot AvailableNot Availableterminated
NCT00710021
Vitamin D3 in Systemic Lupus Erythematosustreatment2completed
NCT01172002
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus NephritistreatmentNot Availableunknown_status
NCT03093402
JBT-101 in Systemic Lupus Erythematosus (SLE)treatment2completed
NCT04065932
A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tabletstreatment1completed
NCT00299819
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)treatment1completed
NCT03952624
Patient-Centered Assessment of Symptoms and OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00581763
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid AntibodiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00053560
To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoidsprevention3unknown_status
NCT03186794
Aerobic Exercise in Women With Systemic Lupus ErythematosusNo drug interventionssupportive_careNot Availableterminated
NCT00657189
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupustreatment2completed
NCT00482989
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosustreatment1completed
NCT02265744
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosusother2completed
NCT01389895
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusNo drug interventionstreatment1terminated
NCT00054938
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)treatment2completed